Blog

All the latest news from Check4Cancer
BeBreastAware - Mammograms
Around one in seven women in the UK are diagnosed with breast cancer¹ at some point in their lives. Early detection rem...
Resetting the consultant dynamic
In the third and final part of a three article series with Laing Buisson Healthcare Markets, Professor Gordon Wishart and Phi...
Be BreastAware - find out about the signs and symptoms of breast cancer
Breast Cancer Awareness Month, marked in countries across the world every October, helps to increase attention and support fo...
Coronavirus: Hidden toll of 25,000 extra deaths in private homes since virus took hold
Between March and September there were 25,000 excess deaths in private homes in England, with the vast majority not linked to...
Covid chaos offers chance to revamp independent practice
Professor Gordon Wishart, chief medical officer at Check4Cancer and Philip Housden, managing director of Housden Group analys...
Male Breast Cancer - know the facts and get checked
Male breast cancer Usually thought of as a disease seen only in women, male breast cancer is a rare but real risk, most ofte...
Professor Simon Russell answers some of the most pressing questions around breast cancer in the second of our ‘Ask the Expert’ blog series
Ask the Expert: Breast Cancer In the second of our Ask the Expert blog series, Professor Simon Russell, Consultant Oncologis...
Professor Richard Hindley answers some of the most pressing questions around prostate cancer in the first of our ‘Ask the Expert’ blog series
Ask the Expert: Prostate Cancer Professor Richard Hindley answers some of the most pressing questions around prostate cancer...
Screening and diagnostics: what’s the difference?
When it comes to cancer, the terms ‘screening’ and ‘diagnostics are often – incorrectly – used interchangeably. Can...
How the pandemic is changing traditional healthcare relationships in the UK
The second of three articles in Laing Buisson Healthcare Markets by Professor Gordon Wishart and Philip Housden, managing dir...
Check4Cancer receives a double nomination in the 2020 Laing Buisson Healthcare Awards
Professor Gordon Wishart is recognised as a ‘Rising Star’ finalist and Check4Cancer is shortlisted as a finalist in the �...
Check4Cancer launches online service to provide fast cancer screening as thousands of people go untested in the Covid-19 pandemic
Check4Cancer, the provider of early cancer detection and genetic services, has launched its new brand and website bringing to...
Resetting the provider/ insurer relationship
The first of three articles in LaingBuisson Healthcare Markets by Professor Gordon Wishart  and Philip Housden, managing...
Potential causal role of human papilloma viruses (HPVs) in prostate cancers
  Professor Gordon Wishart, our Chief Medical Officer comments on the recently published journal ‘Infectious Agents &...
Audit of Check4Cancer’s One Stop Breast Clinic network confirms clinical excellence in the private sector
  Check4Cancer, the reliable and trusted provider of early cancer detection and genetic services in the UK, announces a...
Urgent cancer referrals were wrongly turned down during the pandemic
Professor Gordon Wishart, our Chief Medical Officer speaks with The Daily Mail on the current cancer crisis which has seen ur...
2,800 melanomas could have been missed during Lockdown due to 70% reduction in GP referrals
Professor Gordon Wishart, Chief Medical Officer at Check4Cancer, an early cancer detection company, and Visiting Pr...
Shock warning: 10 million on NHS waiting lists by Christmas
Leading clinicians, including our Chief Medical Officer, Professor Gordon Wishart have written to Boris Johnson warning the U...
Don’t let Lockdown delay your HPV screening test
As the Covid-19 pandemic continues to cause disruption across the country, it is likely that you will have seen delays and ca...
At-home HPV testing for cervical cancer screening could prevent further harm caused by suspension of NHS services during the pandemic
Professor Gordon Wishart, Chief Medical Officer at Check4Cancer discusses how at-home HPV testing for cervical cancer screeni...
Horrendous toll on non-COVID-19 patients emerging
Professor Gordon Wishart, our Chief Medical Officer discusses with ITV News the impact of COVID-19 on cancer diagnosis and treatment.
Thousands of vital cancer treatments missed due to Coronavirus pandemic
Gordon Wishart, our Chief Medical Officer comments in 'The Sunday Express' that the early increase in cancer deaths will be t...
Putting off cancer treatments is 'trading deaths' say experts
Gordon Wishart, our Chief Medical Officer comments in 'The Sunday Express' that delays in cancer diagnosis lead to patients u...
COVID-19 death rates fall below cancer death rates for week ending 22 May 2020
Professor Gordon Wishart, our Chief Medical Officer comments on the news that COVID-19 death rates fall below cancer death ra...